Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Research graph
References from Theranostic Approach Using Radioiodinated Trimethoprim Targeting E. coli Dihydrofolate Reductase in Engineered Cells. Local targets link to admitted publications; unresolved targets remain external evidence.
Incorporating radioligand therapy in clinical practice in the United States for patients with prostate cancer
10.1016/j.ctrv.2023.102524 · 2023 · External reference
10.1056/nejmoa1607427
10.1056/nejmoa1607427 · External reference
10.1056/nejmoa2107322
10.1056/nejmoa2107322 · External reference
10.1056/nejmra1706169
10.1056/nejmra1706169 · External reference
10.1126/science.abm0594
10.1126/science.abm0594 · External reference
10.1517/14712598.2016.1100162
10.1517/14712598.2016.1100162 · External reference
10.1016/j.ymthe.2019.10.007
10.1016/j.ymthe.2019.10.007 · External reference
10.1073/pnas.1703109114
10.1073/pnas.1703109114 · External reference
Imaging sensitive and drug-resistant bacterial infection with [11C]-trimethoprim
10.1172/jci156679 · 2022 · External reference
10.1016/j.ymthe.2016.10.018
10.1016/j.ymthe.2016.10.018 · External reference
10.1016/j.ymthe.2023.10.020
10.1016/j.ymthe.2023.10.020 · External reference
Evaluation of eDHFR/iTag PET reporter gene immunogenicity and application in GPC3 CAR T cells
10.1158/2326-6074.tumimm22-a37 · 2022 · External reference
Targeted in vivo delivery of genetic medicines utilizing an engineered lentiviral vector platform results in CAR T and NK cell generation
10.1016/j.ymthe.2025.06.036 · 2025 · External reference
Efficient in vivo generation of CAR T cells using a retargeted fourth-generation lentiviral vector
10.1016/j.ymthe.2025.07.006 · 2025 · External reference
A genetically targeted reporter for PET imaging of deep neuronal circuits in mammalian brains
10.15252/embj.2021107757 · 2021 · External reference
10.7150/thno.77259
10.7150/thno.77259 · External reference
10.1186/s40580-023-00385-3
10.1186/s40580-023-00385-3 · External reference
Diverse nanoparticles deliver mRNA to enhance tumor immunotherapy
10.5483/bmbrep.2024-0165 · 2025 · External reference
Monitoring mRNA vaccine antigen expression in vivo using PET/CT
10.1038/s41467-025-57446-w · 2025 · External reference
Astatine-211 based radionuclide therapy: current clinical trial landscape
10.3389/fmed.2022.1076210 · 2022 · External reference
10.1002/0470846380.ch14
10.1002/0470846380.ch14 · External reference
10.2967/jnumed.125.270175
10.2967/jnumed.125.270175 · External reference
Halogenated trimethoprim derivatives as multidrug-resistant Staphylococcus aureus therapeutics
10.1016/j.bmc.2018.05.019 · 2018 · External reference
The Stille reaction
2004 · External reference
Iododemetallation of potassium organotrifluoroborates and tributylarylstannanes using sodium iodide/iron(III) chloride
10.1016/j.tetlet.2015.01.010 · 2015 · External reference
Recent advances in synthetic methods for radioiodination
10.1021/acs.joc.0c00644 · 2020 · External reference
Synthesis of radioiodinated compounds. Classical approaches and achievements of recent years
10.3390/ijms232213789 · 2022 · External reference
10.1517/17460441003605098
10.1517/17460441003605098 · External reference
Design of radioiodinated pharmaceuticals: structural features affecting metabolic stability towards in vivo deiodination
10.1002/ejoc.201601638 · 2017 · External reference
10.1016/0360-3016(85)90223-8
10.1016/0360-3016(85)90223-8 · External reference
Fibroblast activation protein-targeted radioligand therapy with 177Lu-EB-FAPI for metastatic radioiodine-refractory thyroid cancer: first-in-human, dose-escalation study
10.1158/1078-0432.ccr-23-1983 · 2023 · External reference
10.1002/cbic.200600414
10.1002/cbic.200600414 · External reference
Preclinical development of [211At]meta-astatobenzylguanidine ([211At]MABG) as an alpha particle radiopharmaceutical therapy for neuroblastoma
10.1158/1078-0432.ccr-22-0400 · 2022 · External reference
Human adult and adolescent biodistribution and dosimetry of the synaptic vesicle glycoprotein 2A radioligand 11C-UCB-J
10.1186/s13550-020-00670-w · 2020 · External reference
10.2967/jnumed.118.225235
10.2967/jnumed.118.225235 · External reference
10.2967/jnumed.114.148437
10.2967/jnumed.114.148437 · External reference
10.2214/ajr.11.6533
10.2214/ajr.11.6533 · External reference
10.1016/j.cell.2011.02.013
10.1016/j.cell.2011.02.013 · External reference
Discriminatory power of combinatorial antigen recognition in cancer T cell therapies
10.1016/j.cels.2020.08.002 · 2020 · External reference
10.1016/j.ymthe.2020.03.016
10.1016/j.ymthe.2020.03.016 · External reference